Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001853
Filing Date
2025-03-14
Accepted
2025-03-14 16:10:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4666
  Complete submission text file 0001950047-25-001853.txt   6152
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Subject) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37478 | Film No.: 25740089
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 13011 MCCALLEN PASS BUILDING A, SUITE 100 AUSTIN TX 78753
Business Address
Rabinowitz Matthew (Reporting) CIK: 0001646382 (see all company filings)

Type: 144